Wang Q, Yang C, Zhou J, Wang X, Wu M, Liu Z
Patients who may particularly benefit from GLP-1 receptor agonists include those with type 2 diabetes and established cardiovascular disease, obesity, or chronic kidney disease (where SGLT2 inhibitors are not suitable or as additional therapy)
Whether that is better or worse than their existing insurance options will depend on their coverage
Whether longer-acting versions, perhaps weekly insulinGLP-1 combinations, are feasible and efficacious requires additional investigation
Just the levels of quinine found in tonic water may cause potentially fatal immunologically-mediated hypersensitivity reactions, basically like allergic reactions, where it interacts with antibodies to trigger autoimmune reactions that can include chills, fever, a drop in blood pressure, painful bluish discoloration of the hands and feet, and clotting within your blood vessels